Florastor IBS
Natural health product licensed in Canada
- Other names
- Florastor IBS - SCI, Florastor IBS Support SCI
- Licence holder
- Biocodex Canada Inc.
- NPN or DIN-HM
- 80139409
- Status
- Active licence
- Licence date
- 20 March 2025
- Revision date
- 24 December 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier | 791 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier | 5.5 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 7,905 FCC HUT | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 11.1 mg | Not calculated |
| Foeniculum vulgare Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 42 mg | 10.5 mg | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 42 mg | 10.5 mg | Not calculated |
| Saccharomyces boulardii Source : Saccharomyces boulardii - Whole Cell | 2.5 Milliards d'UFC | Not calculated |
| Saccharomyces boulardii Source : CNCM I-745 | 2.5 Milliards d'UFC | Not calculated |
| Saccharomyces boulardii Source : Saccharomyces boulardii - Whole Cell | 250 mg | Not calculated |
| Saccharomyces boulardii Source : CNCM I-745 | 250 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 5,270 FCC DU | Not calculated |
| Mentha x piperita Source : Mentha X piperita - feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 42 mg | 10.5 mg | Not calculated |
| Triacylglycérol lipase Source : Candida rugosa - whole | 184 FIP LU | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 3.6 FCC HUT | Not calculated |
| Triacylglycérol lipase Source : Candida rugosa - whole | 0.9 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 3.6 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 44.7 mg | Not calculated |
Non-medicinal ingredients
Lactose monohydraté, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 18 years | 2 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
| Population not specified | minimum: 18 years | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive Aid. Digestive aid to help digest proteins. Digestive enzyme that helps digest proteins. Digestive enzyme. Helps digest proteins. Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Helps to reduce the risk of antibiotic-associated diarrhoea. Source of Probiotics. An adjunct to physician-supervised antibiotic therapy in patients with Helicobacter pylori infections. Daily digestive support and IBS abdominal pain symptom relief. Helps prevent antibiotic associated diarrhea. Helps reduce recurrent Clostridium difficile associated diarrhea when used as an adjunct to antibiotics. Helps to reduce/prevent the risk of traveller's diarrhea. Helps relieve IBS related abdominal pain. Helps provide relief of IBS related abdominal discomfort. Helps to improve stool consistency in adults with IBS Helps to reduce diarrhea related to IBS Helps to relieve symptoms of IBS such as diarrhea and abdominal pain
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80139409
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.